| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.91e-06 | 46 | 39 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 2.22e-05 | 4 | 39 | 2 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 2.22e-05 | 4 | 39 | 2 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 2.22e-05 | 4 | 39 | 2 | GO:0047743 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.11e-05 | 188 | 39 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 3.70e-05 | 5 | 39 | 2 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 3.70e-05 | 5 | 39 | 2 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 3.70e-05 | 5 | 39 | 2 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 3.70e-05 | 5 | 39 | 2 | GO:0047006 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 3.70e-05 | 5 | 39 | 2 | GO:0047787 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 3.70e-05 | 5 | 39 | 2 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 3.70e-05 | 5 | 39 | 2 | GO:0047086 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 5.55e-05 | 6 | 39 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 7.76e-05 | 7 | 39 | 2 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 1.03e-04 | 8 | 39 | 2 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 1.03e-04 | 8 | 39 | 2 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 1.03e-04 | 8 | 39 | 2 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 1.33e-04 | 9 | 39 | 2 | GO:0047044 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 1.33e-04 | 9 | 39 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | NADP+ binding | 1.33e-04 | 9 | 39 | 2 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 1.66e-04 | 10 | 39 | 2 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 1.66e-04 | 10 | 39 | 2 | GO:0032052 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 2.02e-04 | 11 | 39 | 2 | GO:0030283 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 3.33e-04 | 14 | 39 | 2 | GO:0001758 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 3.33e-04 | 14 | 39 | 2 | GO:0004032 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 6.91e-04 | 20 | 39 | 2 | GO:0004303 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 9.98e-04 | 24 | 39 | 2 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.17e-03 | 26 | 39 | 2 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 1.17e-03 | 26 | 39 | 2 | GO:0070402 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.27e-03 | 27 | 39 | 2 | GO:0008106 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.56e-03 | 30 | 39 | 2 | GO:0018455 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 1.78e-03 | 32 | 39 | 2 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.89e-03 | 33 | 39 | 2 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 2.00e-03 | 34 | 39 | 2 | GO:0016628 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 2.63e-03 | 39 | 39 | 2 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.77e-03 | 40 | 39 | 2 | GO:0016709 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 3.66e-03 | 775 | 39 | 6 | GO:0017111 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 3.96e-03 | 48 | 39 | 2 | GO:0016620 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 5.36e-03 | 56 | 39 | 2 | GO:0016903 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 5.39e-03 | 839 | 39 | 6 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 5.42e-03 | 840 | 39 | 6 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 5.42e-03 | 840 | 39 | 6 | GO:0016818 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 6.13e-03 | 60 | 39 | 2 | GO:0016655 | |
| GeneOntologyMolecularFunction | heparin binding | 6.20e-03 | 192 | 39 | 3 | GO:0008201 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 6.53e-03 | 62 | 39 | 2 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 6.53e-03 | 62 | 39 | 2 | GO:0050661 | |
| GeneOntologyMolecularFunction | structural molecule activity | 7.18e-03 | 891 | 39 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 8.26e-03 | 70 | 39 | 2 | GO:1901618 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.05e-02 | 441 | 39 | 4 | GO:0016887 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.13e-02 | 239 | 39 | 3 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.33e-02 | 254 | 39 | 3 | GO:0043177 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.34e-02 | 90 | 39 | 2 | GO:0008028 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 1.08e-05 | 23 | 39 | 3 | GO:0071379 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.27e-05 | 76 | 39 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 2.09e-05 | 4 | 39 | 2 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 2.09e-05 | 4 | 39 | 2 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 2.09e-05 | 4 | 39 | 2 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 2.09e-05 | 4 | 39 | 2 | GO:0008208 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 2.98e-05 | 32 | 39 | 3 | GO:2000353 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 3.47e-05 | 5 | 39 | 2 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 3.47e-05 | 5 | 39 | 2 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 3.47e-05 | 5 | 39 | 2 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 3.47e-05 | 5 | 39 | 2 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 3.47e-05 | 5 | 39 | 2 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 3.47e-05 | 5 | 39 | 2 | GO:1900053 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 4.27e-05 | 36 | 39 | 3 | GO:0034694 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 5.20e-05 | 6 | 39 | 2 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 5.20e-05 | 6 | 39 | 2 | GO:0016095 | |
| GeneOntologyBiologicalProcess | endocardium morphogenesis | 7.27e-05 | 7 | 39 | 2 | GO:0003160 | |
| GeneOntologyBiologicalProcess | tendon development | 7.27e-05 | 7 | 39 | 2 | GO:0035989 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 7.27e-05 | 7 | 39 | 2 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 7.27e-05 | 7 | 39 | 2 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 7.27e-05 | 7 | 39 | 2 | GO:1900052 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 1.24e-04 | 9 | 39 | 2 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 1.55e-04 | 10 | 39 | 2 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 1.55e-04 | 10 | 39 | 2 | GO:0019747 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 1.55e-04 | 10 | 39 | 2 | GO:1903224 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 1.55e-04 | 10 | 39 | 2 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 1.55e-04 | 10 | 39 | 2 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 1.55e-04 | 10 | 39 | 2 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.90e-04 | 11 | 39 | 2 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.90e-04 | 11 | 39 | 2 | GO:0016115 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 1.99e-04 | 60 | 39 | 3 | GO:1904037 | |
| GeneOntologyBiologicalProcess | endocardium development | 2.68e-04 | 13 | 39 | 2 | GO:0003157 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 3.12e-04 | 14 | 39 | 2 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 3.12e-04 | 14 | 39 | 2 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 3.60e-04 | 15 | 39 | 2 | GO:0016102 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell apoptotic process | 3.69e-04 | 74 | 39 | 3 | GO:2000351 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 4.11e-04 | 16 | 39 | 2 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 4.11e-04 | 16 | 39 | 2 | GO:0032351 | |
| GeneOntologyBiologicalProcess | connective tissue development | 4.47e-04 | 343 | 39 | 5 | GO:0061448 | |
| GeneOntologyBiologicalProcess | endothelial cell apoptotic process | 4.47e-04 | 79 | 39 | 3 | GO:0072577 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 5.23e-04 | 18 | 39 | 2 | GO:0030656 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 6.14e-04 | 88 | 39 | 3 | GO:0071277 | |
| GeneOntologyBiologicalProcess | endoderm development | 6.14e-04 | 88 | 39 | 3 | GO:0007492 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 6.86e-04 | 377 | 39 | 5 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 6.94e-04 | 378 | 39 | 5 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 7.03e-04 | 379 | 39 | 5 | GO:0045229 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 7.15e-04 | 21 | 39 | 2 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 7.15e-04 | 21 | 39 | 2 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 7.15e-04 | 21 | 39 | 2 | GO:0048385 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 7.15e-04 | 21 | 39 | 2 | GO:0042574 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 7.15e-04 | 21 | 39 | 2 | GO:0042182 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 7.21e-04 | 93 | 39 | 3 | GO:0099068 | |
| GeneOntologyBiologicalProcess | parturition | 7.86e-04 | 22 | 39 | 2 | GO:0007567 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 7.86e-04 | 22 | 39 | 2 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 7.86e-04 | 22 | 39 | 2 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 7.86e-04 | 22 | 39 | 2 | GO:1902644 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 8.60e-04 | 23 | 39 | 2 | GO:0034310 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 1.10e-03 | 26 | 39 | 2 | GO:0010566 | |
| GeneOntologyBiologicalProcess | cartilage development | 1.12e-03 | 243 | 39 | 4 | GO:0051216 | |
| GeneOntologyBiologicalProcess | inhibitory postsynaptic potential | 1.19e-03 | 27 | 39 | 2 | GO:0060080 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.28e-03 | 28 | 39 | 2 | GO:0048025 | |
| GeneOntologyBiologicalProcess | developmental maturation | 1.35e-03 | 439 | 39 | 5 | GO:0021700 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 1.37e-03 | 29 | 39 | 2 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 1.37e-03 | 29 | 39 | 2 | GO:0050686 | |
| GeneOntologyBiologicalProcess | regulation of cell fate specification | 1.37e-03 | 29 | 39 | 2 | GO:0042659 | |
| GeneOntologyBiologicalProcess | cell fate specification | 1.62e-03 | 123 | 39 | 3 | GO:0001708 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 1.77e-03 | 33 | 39 | 2 | GO:0033119 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.85e-03 | 129 | 39 | 3 | GO:0048024 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.88e-03 | 34 | 39 | 2 | GO:0006706 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 1.88e-03 | 34 | 39 | 2 | GO:0097107 | |
| GeneOntologyBiologicalProcess | cellular response to ketone | 1.89e-03 | 130 | 39 | 3 | GO:1901655 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 1.89e-03 | 130 | 39 | 3 | GO:0097306 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 1.99e-03 | 35 | 39 | 2 | GO:0120255 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 2.02e-03 | 133 | 39 | 3 | GO:0006766 | |
| GeneOntologyBiologicalProcess | heart formation | 2.11e-03 | 36 | 39 | 2 | GO:0060914 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 2.11e-03 | 36 | 39 | 2 | GO:0008299 | |
| GeneOntologyBiologicalProcess | endodermal cell differentiation | 2.35e-03 | 38 | 39 | 2 | GO:0035987 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 2.35e-03 | 38 | 39 | 2 | GO:0048384 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 2.60e-03 | 40 | 39 | 2 | GO:0042573 | |
| GeneOntologyCellularComponent | collagen trimer | 1.37e-08 | 88 | 39 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 5.99e-08 | 5 | 39 | 3 | GO:0005592 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.31e-06 | 12 | 39 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.31e-06 | 12 | 39 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 7.80e-06 | 21 | 39 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.14e-04 | 530 | 39 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 9.12e-04 | 24 | 39 | 2 | GO:0098985 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.26e-03 | 656 | 39 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.28e-03 | 658 | 39 | 6 | GO:0030312 | |
| GeneOntologyCellularComponent | basement membrane | 1.52e-03 | 122 | 39 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.52e-03 | 31 | 39 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | synaptic cleft | 1.73e-03 | 33 | 39 | 2 | GO:0043083 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 3.32e-03 | 332 | 39 | 4 | GO:0005788 | |
| Domain | Collagen | 1.82e-08 | 85 | 38 | 6 | PF01391 | |
| Domain | Collagen | 1.82e-08 | 85 | 38 | 6 | IPR008160 | |
| Domain | TSPN | 1.25e-07 | 23 | 38 | 4 | SM00210 | |
| Domain | NC1_FIB | 1.27e-06 | 11 | 38 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 1.27e-06 | 11 | 38 | 3 | IPR000885 | |
| Domain | Fib_collagen_C | 1.27e-06 | 11 | 38 | 3 | PD002078 | |
| Domain | COLFI | 1.27e-06 | 11 | 38 | 3 | SM00038 | |
| Domain | COLFI | 1.27e-06 | 11 | 38 | 3 | PF01410 | |
| Domain | LamG | 1.87e-06 | 44 | 38 | 4 | SM00282 | |
| Domain | Laminin_G | 5.71e-06 | 58 | 38 | 4 | IPR001791 | |
| Domain | Laminin_G_2 | 7.29e-05 | 40 | 38 | 3 | PF02210 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.80e-04 | 10 | 38 | 2 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 1.80e-04 | 10 | 38 | 2 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.80e-04 | 10 | 38 | 2 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.80e-04 | 10 | 38 | 2 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.80e-04 | 10 | 38 | 2 | PS00063 | |
| Domain | - | 4.75e-04 | 16 | 38 | 2 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 5.38e-04 | 17 | 38 | 2 | IPR023210 | |
| Domain | Aldo_ket_red | 5.38e-04 | 17 | 38 | 2 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 5.38e-04 | 17 | 38 | 2 | IPR001395 | |
| Domain | - | 9.45e-04 | 95 | 38 | 3 | 2.60.120.200 | |
| Domain | ConA-like_dom | 9.93e-04 | 219 | 38 | 4 | IPR013320 | |
| Domain | C1Q | 1.92e-03 | 32 | 38 | 2 | SM00110 | |
| Domain | C1q | 1.92e-03 | 32 | 38 | 2 | PF00386 | |
| Domain | C1q_dom | 2.17e-03 | 34 | 38 | 2 | IPR001073 | |
| Domain | C1Q | 2.17e-03 | 34 | 38 | 2 | PS50871 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.30e-03 | 35 | 38 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 2.71e-03 | 38 | 38 | 2 | PS00690 | |
| Domain | - | 4.64e-03 | 50 | 38 | 2 | 2.60.120.40 | |
| Domain | - | 5.59e-03 | 55 | 38 | 2 | 1.10.30.10 | |
| Domain | Tumour_necrosis_fac-like_dom | 6.20e-03 | 58 | 38 | 2 | IPR008983 | |
| Domain | P-loop_NTPase | 6.85e-03 | 848 | 38 | 6 | IPR027417 | |
| Domain | HMG_box_dom | 7.73e-03 | 65 | 38 | 2 | IPR009071 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.37e-06 | 41 | 33 | 4 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.16e-06 | 44 | 33 | 4 | M27812 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 5.31e-06 | 50 | 33 | 4 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 6.72e-06 | 53 | 33 | 4 | MM14566 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.10e-05 | 19 | 33 | 3 | MM15512 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.18e-05 | 61 | 33 | 4 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.18e-05 | 61 | 33 | 4 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.43e-05 | 64 | 33 | 4 | M26953 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.62e-05 | 66 | 33 | 4 | M18 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.72e-05 | 67 | 33 | 4 | M26999 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.83e-05 | 76 | 33 | 4 | MM14573 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 4.55e-05 | 30 | 33 | 3 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.55e-05 | 30 | 33 | 3 | MM15517 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 5.52e-05 | 90 | 33 | 4 | M631 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 5.53e-05 | 32 | 33 | 3 | MM14924 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.17e-04 | 41 | 33 | 3 | M27778 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.39e-04 | 114 | 33 | 4 | MM14571 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.66e-04 | 46 | 33 | 3 | M198 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 1.89e-04 | 9 | 33 | 2 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 1.89e-04 | 9 | 33 | 2 | M47817 | |
| Pathway | REACTOME_GASTRULATION | 2.23e-04 | 129 | 33 | 4 | M46433 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 2.88e-04 | 11 | 33 | 2 | M47812 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.05e-04 | 140 | 33 | 4 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.08e-04 | 258 | 33 | 5 | MM14572 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.47e-04 | 59 | 33 | 3 | M27218 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 4.08e-04 | 13 | 33 | 2 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 4.08e-04 | 13 | 33 | 2 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 4.75e-04 | 14 | 33 | 2 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 4.75e-04 | 14 | 33 | 2 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 4.75e-04 | 14 | 33 | 2 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 4.75e-04 | 14 | 33 | 2 | MM14748 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 5.06e-04 | 67 | 33 | 3 | MM15345 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 5.47e-04 | 15 | 33 | 2 | MM14870 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.14e-04 | 300 | 33 | 5 | M610 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 6.77e-04 | 74 | 33 | 3 | M160 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 8.19e-04 | 79 | 33 | 3 | M27643 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 9.79e-04 | 84 | 33 | 3 | M7098 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.30e-03 | 23 | 33 | 2 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.30e-03 | 23 | 33 | 2 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.30e-03 | 23 | 33 | 2 | MM14741 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.93e-03 | 28 | 33 | 2 | MM15188 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.22e-03 | 30 | 33 | 2 | M27216 | |
| Pathway | REACTOME_DRUG_ADME | 2.66e-03 | 119 | 33 | 3 | MM15692 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.68e-03 | 33 | 33 | 2 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.68e-03 | 33 | 33 | 2 | MM14737 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 34009784 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 36553626 | ||
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 5.21e-09 | 4 | 39 | 3 | 17683922 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 8.98e-09 | 135 | 39 | 6 | 28675934 | |
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 21467034 | ||
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 10722718 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 2.60e-08 | 6 | 39 | 3 | 8563024 | |
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 17876790 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 7.27e-08 | 8 | 39 | 3 | 20059976 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 7560887 | ||
| Pubmed | Collagen XI sequence variations in nonsyndromic cleft palate, Robin sequence and micrognathia. | 1.23e-06 | 2 | 39 | 2 | 12673280 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29781737 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 7650035 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 33348901 | ||
| Pubmed | Structure of a full-length cDNA clone for the pro-alpha1(V/XI) collagen chain of red seabream. | 1.23e-06 | 2 | 39 | 2 | 11342118 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 11780999 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 7721876 | ||
| Pubmed | Differential in situ expression of alpha2(XI) collagen mRNA isoforms in the developing mouse. | 1.23e-06 | 2 | 39 | 2 | 9560475 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 2591970 | ||
| Pubmed | Immunohistochemical localization of collagen type XI alpha1 and alpha2 chains in human colon tissue. | 1.23e-06 | 2 | 39 | 2 | 18040076 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 25240749 | ||
| Pubmed | 1.53e-06 | 175 | 39 | 5 | 28071719 | ||
| Pubmed | SOX17 PSMC4 ANKRD17 ZBTB7A SSBP2 CHD3 CEP192 KMT2B KAT14 RBPJ | 2.84e-06 | 1429 | 39 | 10 | 35140242 | |
| Pubmed | 2.95e-06 | 25 | 39 | 3 | 19180518 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 7626489 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15141750 | ||
| Pubmed | cDNA sequence and expression of the mouse alpha1(V) collagen gene (Col5a1). | 3.67e-06 | 3 | 39 | 2 | 9582436 | |
| Pubmed | Diurnal regulation of metabolism by Gs-alpha in hypothalamic QPLOT neurons. | 3.67e-06 | 3 | 39 | 2 | 37141220 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ANKRD17 COL5A1 COL18A1 ZBTB7A CHD3 IGSF9B CEP192 GNAS NUMBL RTEL1 | 4.09e-06 | 1489 | 39 | 10 | 28611215 |
| Pubmed | 4.67e-06 | 29 | 39 | 3 | 22613833 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 20124700 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 21527992 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 10702227 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 17034817 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 7.34e-06 | 4 | 39 | 2 | 10500239 | |
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 7.34e-06 | 4 | 39 | 2 | 16508162 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 19487289 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 17629694 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 7.34e-06 | 4 | 39 | 2 | 14967952 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 7.34e-06 | 4 | 39 | 2 | 15193432 | |
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 7.34e-06 | 4 | 39 | 2 | 29764944 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 10526179 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 17888864 | ||
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 7.34e-06 | 4 | 39 | 2 | 31479646 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 17442338 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 28329705 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 16018803 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 17272929 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 19237748 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 7.34e-06 | 4 | 39 | 2 | 18667791 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 15222881 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 28259989 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 16191478 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 21521174 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 8274401 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 16511129 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 10803568 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 23624467 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 7.34e-06 | 4 | 39 | 2 | 34590152 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 15577209 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 7789999 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 8.36e-06 | 248 | 39 | 5 | 24006456 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 7737980 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 10672042 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 1.22e-05 | 5 | 39 | 2 | 21851338 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 38788959 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 17872381 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 1.22e-05 | 5 | 39 | 2 | 16984997 | |
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 1.22e-05 | 5 | 39 | 2 | 17064890 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 18003893 | ||
| Pubmed | Deletion of Pax1 scoliosis-associated regulatory elements leads to a female-biased tail abnormality. | 1.83e-05 | 6 | 39 | 2 | 38461417 | |
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 1.83e-05 | 6 | 39 | 2 | 29107092 | |
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 1.83e-05 | 6 | 39 | 2 | 17029294 | |
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 1.83e-05 | 6 | 39 | 2 | 26748576 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 1.83e-05 | 6 | 39 | 2 | 17255200 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 19273550 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 15922184 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 15860270 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 15471942 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 37843276 | ||
| Pubmed | The molecular chaperone Hsp47 is essential for cartilage and endochondral bone formation. | 1.83e-05 | 6 | 39 | 2 | 22492985 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 20301479 | ||
| Pubmed | 2.26e-05 | 1084 | 39 | 8 | 11544199 | ||
| Pubmed | 2.46e-05 | 50 | 39 | 3 | 23658023 | ||
| Pubmed | Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. | 2.56e-05 | 7 | 39 | 2 | 26816381 | |
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 2.56e-05 | 7 | 39 | 2 | 34843575 | |
| Pubmed | Reciprocal signalling by Notch-Collagen V-CALCR retains muscle stem cells in their niche. | 2.56e-05 | 7 | 39 | 2 | 29795344 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 22529366 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 17324935 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 33127481 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 12562828 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 26160177 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 16337335 | ||
| Pubmed | Osteopetrosis in TAK1-deficient mice owing to defective NF-κB and NOTCH signaling. | 2.56e-05 | 7 | 39 | 2 | 25535389 | |
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 18816857 | ||
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 20837989 | ||
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 33584538 | ||
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 9224647 | ||
| Cytoband | 20q13.3 | 1.32e-04 | 20 | 39 | 2 | 20q13.3 | |
| Cytoband | 4p15.2 | 2.62e-04 | 28 | 39 | 2 | 4p15.2 | |
| Cytoband | 1p34.1 | 1.09e-03 | 57 | 39 | 2 | 1p34.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 2.69e-03 | 90 | 39 | 2 | chr10p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p15 | 5.92e-03 | 135 | 39 | 2 | chr4p15 | |
| GeneFamily | Collagens | 9.57e-07 | 46 | 30 | 4 | 490 | |
| GeneFamily | Aldo-keto reductases | 2.76e-04 | 15 | 30 | 2 | 399 | |
| Coexpression | NABA_COLLAGENS | 4.45e-07 | 43 | 38 | 4 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 4.89e-07 | 44 | 38 | 4 | M3005 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.00e-05 | 29 | 38 | 3 | MM17055 | |
| Coexpression | NABA_CORE_MATRISOME | 4.25e-05 | 270 | 38 | 5 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 4.63e-05 | 275 | 38 | 5 | M5884 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 5.03e-05 | 685 | 38 | 7 | MM3782 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 9.68e-05 | 166 | 38 | 4 | M1542 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.10e-04 | 64 | 38 | 3 | M2572 | |
| Coexpression | LIAO_METASTASIS | 1.17e-04 | 540 | 38 | 6 | M13809 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 1.29e-04 | 179 | 38 | 4 | MM660 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | 1.55e-04 | 1106 | 38 | 8 | M39071 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | 1.77e-04 | 75 | 38 | 3 | M1956 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_UP | 1.91e-04 | 198 | 38 | 4 | M8878 | |
| Coexpression | GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN | 1.98e-04 | 200 | 38 | 4 | M9668 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | 2.65e-04 | 86 | 38 | 3 | MM834 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 2.75e-04 | 17 | 38 | 2 | MM826 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP | 2.80e-04 | 219 | 38 | 4 | MM1237 | |
| Coexpression | ZAMORA_NOS2_TARGETS_DN | 2.93e-04 | 89 | 38 | 3 | MM690 | |
| Coexpression | JIANG_MELANOMA_TRM7_CD8 | 3.03e-04 | 90 | 38 | 3 | M48971 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 3.09e-04 | 18 | 38 | 2 | M47984 | |
| ToppCell | (3)_Chondrocytes-(31)_Chondro-hyper|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.36e-07 | 189 | 39 | 5 | 394b153393904c3dba51a6bfe338afd554e66649 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-07 | 200 | 39 | 5 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| ToppCell | lymphoid-B_cell-pro-B|World / Lineage, cell class and subclass | 1.18e-05 | 161 | 39 | 4 | 23138e579f07d5a6f20d41457cb573b4ac95a4ef | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 180 | 39 | 4 | fa819df81fca95c2cc602fede635cb03e3f35fad | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 180 | 39 | 4 | 907cd510fd2e21532ce04ba687e8894f7af71f27 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 182 | 39 | 4 | c00e503f442d44fbae73c5e2dc85be69e294e67a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-05 | 185 | 39 | 4 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.26e-05 | 190 | 39 | 4 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.26e-05 | 190 | 39 | 4 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | (3)_Chondrocytes-(33)_Chondro-prol/rest|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.45e-05 | 194 | 39 | 4 | c093c5e161b97ad770bfbaad3023eba4537101b5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.45e-05 | 194 | 39 | 4 | 40c6e17e9e48d4fa6da3a0a1066c4c6565a1e096 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 195 | 39 | 4 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-05 | 196 | 39 | 4 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 196 | 39 | 4 | 59b5b5a0c123d0423abd19c312514849004b903b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-05 | 196 | 39 | 4 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 197 | 39 | 4 | b16add329bb35a558287ede51353010dde5bc029 | |
| ToppCell | (4)_Endothelial_cells-(41)_EC-arteriolar|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.60e-05 | 197 | 39 | 4 | 482e3f8926880afed88ed37553ed2b5ed58b8c99 | |
| ToppCell | droplet-Heart-HEART|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 197 | 39 | 4 | 9654472f1d4c9a6caadf1ff61a84902d171e9eb4 | |
| ToppCell | droplet-Heart-HEART-1m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 197 | 39 | 4 | 1ec3c05a5d4163df2cf0d168e28a3f1d35364da2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.65e-05 | 198 | 39 | 4 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 198 | 39 | 4 | 885cbd3695b466a161cf318d35ebbdfcc0c19cec | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.65e-05 | 198 | 39 | 4 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 198 | 39 | 4 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.65e-05 | 198 | 39 | 4 | 65875fbd99393cdd62595c713ab90db06d28081f | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.71e-05 | 199 | 39 | 4 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.76e-05 | 200 | 39 | 4 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.76e-05 | 200 | 39 | 4 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Npw|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.32e-04 | 113 | 39 | 3 | 165de4316059222f33d1e51aeff4554037c0b937 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.14e-04 | 133 | 39 | 3 | 63d2f096ae47d9b587acc6c5fbd346e5e58842b8 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.38e-04 | 138 | 39 | 3 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.70e-04 | 144 | 39 | 3 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.81e-04 | 146 | 39 | 3 | a317f14a1aab11ffcce65baeb1c475c04324315f | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 2.86e-04 | 147 | 39 | 3 | 87c24843cb0e87ad42e725d08423131a5d2d25a3 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.22e-04 | 153 | 39 | 3 | b37a1ecad389d2848b8ca4d287823e8048207420 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 3.28e-04 | 154 | 39 | 3 | 8a8c3851888ab86ca2b13ccc042cde1fef8d88f8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.35e-04 | 155 | 39 | 3 | 7aba8ef53c9170ad8ed955c904c8991097ab1e32 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 156 | 39 | 3 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 156 | 39 | 3 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.41e-04 | 156 | 39 | 3 | 60f1ce38e34b582f589db1e0d6139282c1902b2b | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 3.67e-04 | 160 | 39 | 3 | ab769516f9f7798d1390ef215caf22a2d3d53e63 | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|(1)_Control_(PBS) / Stress and Cell class | 3.67e-04 | 160 | 39 | 3 | 8450466fc2465c56798df2b520edd23c2c2e941c | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 161 | 39 | 3 | f1d3287d9cb4e0eec99b3509f5dc4b87ae8c8cc9 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 161 | 39 | 3 | 110cc7122e3c9f105a11d811d77c8a8852b9de6c | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-04 | 163 | 39 | 3 | 7af3d3ae7e0de733a18d0486c7ffbb5a7ef7230a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-04 | 165 | 39 | 3 | 1703d3eb644b3c743ad3c5532b1d29ea010c79c8 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.09e-04 | 166 | 39 | 3 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.09e-04 | 166 | 39 | 3 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-04 | 167 | 39 | 3 | 881f64db8dea3faa7588bf04d87c20924a4e5952 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.38e-04 | 170 | 39 | 3 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-04 | 170 | 39 | 3 | 37c647f67505aa1ff12a198df1eeddd9f406fe15 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-04 | 170 | 39 | 3 | b180ec9a1b79025a180c8559c27c31272410dea8 | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.46e-04 | 171 | 39 | 3 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.53e-04 | 172 | 39 | 3 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-04 | 172 | 39 | 3 | afa36501d48b1456c511fa0d5d326ec05bdc380f | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.53e-04 | 172 | 39 | 3 | 84d16cd7f618c94888920680bdc9e7130d73fd75 | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 4.53e-04 | 172 | 39 | 3 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | Ionocyte-iono-2|World / Class top | 4.61e-04 | 173 | 39 | 3 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 4.61e-04 | 173 | 39 | 3 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-04 | 174 | 39 | 3 | 6987fe7959afce347282f632abc16d800ccab7c4 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-ILC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.69e-04 | 174 | 39 | 3 | 7c50bf9da37711266cc077eef4e54b58463f1d37 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 4.69e-04 | 174 | 39 | 3 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-04 | 175 | 39 | 3 | d3890bd0c570bb81434fdd1c5229891cefe2e462 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 175 | 39 | 3 | 1d1cdbf3221b03e24eae38afd57cbd6736b37a53 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.77e-04 | 175 | 39 | 3 | 085cceb1fc2c4ae2f27e85cea5702defecc2cf44 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 175 | 39 | 3 | d67c77eee979ad029e7545f383326f0ff77c6e5f | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.85e-04 | 176 | 39 | 3 | 2015539c58aa0bb118e111ffedd63dd9fe863bb1 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.85e-04 | 176 | 39 | 3 | 7d1e2627d7ec5ddd6c87c55d2a6879255b76949e | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.85e-04 | 176 | 39 | 3 | 792f414f5092aba14260b8e16378e793a822498e | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.01e-04 | 178 | 39 | 3 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.01e-04 | 178 | 39 | 3 | f94e306b9550f3d1b5de0bb806790c17823d439e | |
| ToppCell | Entopeduncular-Macroglia|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.09e-04 | 179 | 39 | 3 | f61974710a60aa0618fdb30d864fb9bc7c05ef21 | |
| ToppCell | Mesenchymal_cells-Chondrocytes|Mesenchymal_cells / Lineage and Cell class | 5.18e-04 | 180 | 39 | 3 | 6e399368430ef3afa9ce1ef0ed90f614ccef9987 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 5.26e-04 | 181 | 39 | 3 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 181 | 39 | 3 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 181 | 39 | 3 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 181 | 39 | 3 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 181 | 39 | 3 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 181 | 39 | 3 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.35e-04 | 182 | 39 | 3 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | d568a8aec7e27ce632e248baea2ccd0e8dd255ac | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.35e-04 | 182 | 39 | 3 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.35e-04 | 182 | 39 | 3 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.35e-04 | 182 | 39 | 3 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-04 | 182 | 39 | 3 | b4f347fb684f6840c166d7473f3f56389f69c14b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | 82ca6d5ed48b4c487ce00b9309255abb8f20b61d | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.35e-04 | 182 | 39 | 3 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.43e-04 | 183 | 39 | 3 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.43e-04 | 183 | 39 | 3 | 1464b5c4425e8776c4aeb4d2b560481d4bf13931 | |
| ToppCell | wk_15-18-Epithelial-PNS-intermediate_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.43e-04 | 183 | 39 | 3 | d874aa9a856f79626c8a8371f6196a77b7d662ee | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.52e-04 | 184 | 39 | 3 | 30fddbc9696476d4d7f08e53f84ea994a4ed873a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.52e-04 | 184 | 39 | 3 | 96926efa220f03d0787322c9519bb9e8f64f74d0 | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 5.52e-04 | 184 | 39 | 3 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-04 | 184 | 39 | 3 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 185 | 39 | 3 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 185 | 39 | 3 | 11c147f3f5570c4761d2bcff3bad28146b4a5861 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 5.61e-04 | 185 | 39 | 3 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 185 | 39 | 3 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-04 | 186 | 39 | 3 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| Drug | GK-101 | 4.16e-07 | 36 | 39 | 4 | CID000161853 | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.03e-06 | 198 | 39 | 6 | 7035_UP | |
| Drug | Madecassol | 1.14e-06 | 46 | 39 | 4 | CID000108062 | |
| Drug | hydroxylysine | 1.16e-06 | 109 | 39 | 5 | CID000001029 | |
| Drug | AC1L1C2F | 1.21e-06 | 110 | 39 | 5 | CID000001711 | |
| Drug | d-indobufen | 1.60e-06 | 50 | 39 | 4 | CID000044562 | |
| Drug | ridogrel | 1.88e-06 | 52 | 39 | 4 | CID005362391 | |
| Drug | NSC49633 | 2.03e-06 | 53 | 39 | 4 | CID000023340 | |
| Drug | AC1LAKND | 3.82e-06 | 62 | 39 | 4 | CID000470146 | |
| Drug | 351A | 5.19e-06 | 20 | 39 | 3 | CID000122144 | |
| Drug | BAPN | 6.57e-06 | 71 | 39 | 4 | CID000001647 | |
| Drug | malotilate | 6.57e-06 | 71 | 39 | 4 | CID000004006 | |
| Drug | L-3,4-dehydroproline | 7.35e-06 | 73 | 39 | 4 | CID000094284 | |
| Drug | AC1NMZ1B | 8.18e-06 | 75 | 39 | 4 | CID005034185 | |
| Drug | strontium ranelate | 9.09e-06 | 77 | 39 | 4 | CID006918182 | |
| Drug | halofuginone lactate | 1.35e-05 | 85 | 39 | 4 | CID000062891 | |
| Drug | Pregnanes | 1.71e-05 | 4 | 39 | 2 | ctd:D011278 | |
| Drug | tetralol | 1.71e-05 | 4 | 39 | 2 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 1.71e-05 | 4 | 39 | 2 | ctd:C018156 | |
| Drug | cloxazolam | 1.71e-05 | 4 | 39 | 2 | ctd:C005522 | |
| Drug | DBD-H | 1.71e-05 | 4 | 39 | 2 | CID000131382 | |
| Drug | 4-hydroxyproline | 1.76e-05 | 91 | 39 | 4 | CID000000825 | |
| Drug | isodesmosine | 2.45e-05 | 33 | 39 | 3 | CID000013811 | |
| Drug | Hydroxysteroids | 2.85e-05 | 5 | 39 | 2 | ctd:D006914 | |
| Drug | cresolphthalein | 2.85e-05 | 5 | 39 | 2 | ctd:C010092 | |
| Drug | ticlopidine | 2.88e-05 | 103 | 39 | 4 | CID000005472 | |
| Drug | PPACK | 4.14e-05 | 113 | 39 | 4 | CID003036757 | |
| Drug | BPAT-143 | 4.27e-05 | 6 | 39 | 2 | CID000146249 | |
| Drug | AC1L93E5 | 4.27e-05 | 6 | 39 | 2 | CID000412383 | |
| Drug | Medazepam | 4.27e-05 | 6 | 39 | 2 | ctd:D008472 | |
| Drug | 3-hydroxyhexobarbital | 4.27e-05 | 6 | 39 | 2 | CID000439898 | |
| Drug | B-Ms | 4.28e-05 | 114 | 39 | 4 | CID000445091 | |
| Drug | AC1L9732 | 4.28e-05 | 114 | 39 | 4 | CID000439300 | |
| Drug | AC1Q6PCP | 4.38e-05 | 230 | 39 | 5 | CID000005267 | |
| Drug | Tranilast sodium | 4.43e-05 | 115 | 39 | 4 | CID000005527 | |
| Drug | PD123177 | 5.47e-05 | 43 | 39 | 3 | CID000114899 | |
| Drug | NC-4 | 5.86e-05 | 44 | 39 | 3 | CID006420119 | |
| Drug | Selara | 6.14e-05 | 125 | 39 | 4 | CID000150310 | |
| Drug | DMSe | 7.59e-05 | 132 | 39 | 4 | CID000020796 | |
| Drug | 2-cyclohexen-1-ol | 7.95e-05 | 8 | 39 | 2 | CID000013198 | |
| Drug | Nitrazepam | 7.95e-05 | 8 | 39 | 2 | ctd:D009567 | |
| Drug | pirfenidone | 9.01e-05 | 138 | 39 | 4 | CID000040632 | |
| Drug | DL-penicillamine | 9.27e-05 | 139 | 39 | 4 | CID000004727 | |
| Drug | PCR 4099 | 9.27e-05 | 139 | 39 | 4 | CID000002806 | |
| Drug | 4-hydroxybenzoic acid | 1.02e-04 | 9 | 39 | 2 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 1.02e-04 | 9 | 39 | 2 | ctd:D004092 | |
| Drug | desmosine | 1.03e-04 | 53 | 39 | 3 | CID000025435 | |
| Drug | NADH | 1.06e-04 | 144 | 39 | 4 | DB00157 | |
| Drug | candesartan cilexetil | 1.09e-04 | 145 | 39 | 4 | CID000002540 | |
| Drug | Hexestrol | 1.15e-04 | 55 | 39 | 3 | ctd:D006589 | |
| Drug | 1h00 | 1.21e-04 | 56 | 39 | 3 | CID000445950 | |
| Drug | octyl gallate | 1.28e-04 | 10 | 39 | 2 | ctd:C016627 | |
| Drug | N-isopropyl-p-iodoamphetamine | 1.56e-04 | 11 | 39 | 2 | CID000003729 | |
| Drug | Dihydroxydihydrobenzopyrenes | 1.56e-04 | 11 | 39 | 2 | ctd:D004101 | |
| Drug | chlordecone alcohol | 1.56e-04 | 11 | 39 | 2 | CID000013946 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.67e-04 | 162 | 39 | 4 | CID000072363 | |
| Drug | Phenolphthalein | 1.87e-04 | 12 | 39 | 2 | ctd:D020113 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 1.89e-04 | 314 | 39 | 5 | CID000447989 | |
| Drug | khellin | 2.06e-04 | 171 | 39 | 4 | CID000003828 | |
| Drug | Alendronate | 2.16e-04 | 68 | 39 | 3 | ctd:D019386 | |
| Drug | DMBA-3,4-dihydrodiol | 2.20e-04 | 13 | 39 | 2 | CID000050096 | |
| Drug | flunisolide | 2.20e-04 | 13 | 39 | 2 | ctd:C007734 | |
| Drug | AC1L1DD6 | 2.45e-04 | 179 | 39 | 4 | CID000002299 | |
| Drug | 1-acenaphthenol | 2.57e-04 | 14 | 39 | 2 | CID000022750 | |
| Drug | 5-alpha-Dihydroprogesterone | 2.57e-04 | 14 | 39 | 2 | ctd:D043582 | |
| Drug | Meclofenamic Acid | 2.57e-04 | 14 | 39 | 2 | ctd:D008469 | |
| Drug | 5 alpha-androstane-3 beta,17 beta-diol | 2.78e-04 | 185 | 39 | 4 | CID000011301 | |
| Drug | reduced diphosphopyridine nucleotide | 2.81e-04 | 342 | 39 | 5 | CID000000928 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 3.01e-04 | 189 | 39 | 4 | CID000001413 | |
| Drug | foscarnet | 3.08e-04 | 190 | 39 | 4 | CID000003414 | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A | 3.08e-04 | 190 | 39 | 4 | 6318_DN | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 3.14e-04 | 191 | 39 | 4 | 2789_DN | |
| Drug | alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 4531_UP | |
| Drug | 9-cis-retinal | 3.38e-04 | 16 | 39 | 2 | ctd:C031390 | |
| Drug | rhamnose | 3.38e-04 | 356 | 39 | 5 | CID000000840 | |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 7022_UP | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 7470_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; HL60; HG-U133A | 3.46e-04 | 196 | 39 | 4 | 1982_UP | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 5671_UP | |
| Drug | Sulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 3218_DN | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 2065_UP | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 6603_DN | |
| Drug | Chlorhexidine [55-56-1]; Down 200; 8uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 6302_DN | |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 7212_DN | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A | 3.74e-04 | 200 | 39 | 4 | 2077_UP | |
| Drug | Edrophonium chloride [116-38-1]; Down 200; 19.8uM; MCF7; HT_HG-U133A | 3.74e-04 | 200 | 39 | 4 | 5001_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; PC3; HT_HG-U133A | 3.74e-04 | 200 | 39 | 4 | 6907_DN | |
| Drug | beta-Naphthoflavone | 4.56e-04 | 828 | 39 | 7 | ctd:D019324 | |
| Drug | oxcarbazepine | 4.80e-04 | 19 | 39 | 2 | ctd:C036006 | |
| Drug | AC1L9HPX | 5.25e-04 | 92 | 39 | 3 | CID000445279 | |
| Drug | benzo(a)pyrene-7,8-dione | 5.33e-04 | 20 | 39 | 2 | ctd:C076588 | |
| Drug | Chrysenes | 5.33e-04 | 20 | 39 | 2 | ctd:D002911 | |
| Drug | AGN-1133 | 5.42e-04 | 93 | 39 | 3 | CID000015178 | |
| Drug | Flunitrazepam | 5.88e-04 | 21 | 39 | 2 | ctd:D005445 | |
| Drug | benzene dihydrodiol | 6.46e-04 | 22 | 39 | 2 | CID000000418 | |
| Drug | alpha-L-rhamnoside | 6.50e-04 | 99 | 39 | 3 | CID000019233 | |
| Drug | pyridinoline | 6.50e-04 | 99 | 39 | 3 | CID000105068 | |
| Drug | chondroitin sulfate | 6.64e-04 | 413 | 39 | 5 | CID000024766 | |
| Disease | Fibrochondrogenesis | 1.61e-06 | 2 | 38 | 2 | C0265282 | |
| Disease | Stickler syndrome (implicated_via_orthology) | 1.61e-06 | 2 | 38 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | Stickler syndrome | 1.61e-05 | 5 | 38 | 2 | cv:C0265253 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.42e-05 | 53 | 38 | 3 | C4707243 | |
| Disease | glioblastoma multiforme | 5.78e-05 | 9 | 38 | 2 | EFO_0000519 | |
| Disease | waist-hip ratio | 1.40e-04 | 1226 | 38 | 8 | EFO_0004343 | |
| Disease | triacylglycerol 54:6 measurement | 3.67e-04 | 22 | 38 | 2 | EFO_0010424 | |
| Disease | Headache, type 2 diabetes mellitus | 4.02e-04 | 23 | 38 | 2 | HP_0002315, MONDO_0005148 | |
| Disease | age-related hearing impairment | 7.85e-04 | 324 | 38 | 4 | EFO_0005782 | |
| Disease | Hereditary hearing loss and deafness | 8.82e-04 | 146 | 38 | 3 | cv:C0236038 | |
| Disease | triglyceride measurement, response to diuretic | 8.83e-04 | 34 | 38 | 2 | EFO_0004530, GO_0036270 | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 9.35e-04 | 35 | 38 | 2 | DOID:0050861 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | 1.11e-03 | 616 | 38 | 5 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.11e-03 | 616 | 38 | 5 | C0376358 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPEPGPFPGIVDMFG | 151 | Q86TX2 | |
| MPVLGFGTYAPPEVP | 16 | P17516 | |
| MLGPAPYDPGAGLVI | 386 | Q96LX7 | |
| MPVLGFGTYAPPEVP | 16 | P42330 | |
| DPPLMAGDGPQYLFP | 556 | Q6P1W5 | |
| YGNAMIPPVAPIPDG | 2536 | O75179 | |
| GLGYPPMPRVPVVGI | 496 | Q9Y6R0 | |
| MAGPGPGPGDPDEQY | 1 | Q86YS6 | |
| MPPAVGGPVGYTPPD | 1 | P53985 | |
| PAVVEPGMLVEGPPG | 431 | P12107 | |
| PGPPGPVVYVSEQDG | 1121 | P39060 | |
| GVIDPGMEYVPPPAG | 376 | Q9H8E8 | |
| VKQDMPPPGGYGPID | 6 | Q9P0J0 | |
| MPLVGLGDYVPEPFG | 166 | Q6U736 | |
| LEPGMLVEGPPGPEG | 391 | P13942 | |
| PPMDDVYAPGELGPG | 406 | Q03052 | |
| FVKMAGEGEPVPPPV | 2201 | Q9UMN6 | |
| GDEVPYVLGIPMIGP | 546 | Q8N2Q7 | |
| FPGAPVGMLGEDPPV | 1156 | O75161 | |
| QPYPDGGPVPSEMDV | 421 | Q14112 | |
| PMGIPGEPGEEGRYK | 101 | P02747 | |
| MICDPYTAAPGGEPP | 31 | Q7Z5L3 | |
| VPGVPGEMEPEPGYR | 1621 | Q12873 | |
| IEPGMLIEGPPGPEG | 461 | P20908 | |
| IPGMIYEDLEGPEPP | 236 | Q8TEP8 | |
| TYSMEGPPEDPGIVP | 491 | Q96AC6 | |
| TGRPYPGMEPPGPQE | 1136 | Q9NZ71 | |
| VSDYAGPPEPPAGPM | 256 | Q9H6I2 | |
| DGMPVGPVPPGFFQP | 111 | P81877 | |
| IDPPRGVLMYGPPGC | 196 | P43686 | |
| MIYGDPPPEVIGIPL | 66 | P35499 | |
| KAGYITPVPGGVGPM | 301 | P13995 | |
| LGGYSPPPEEAMPFE | 151 | Q5JWF2 | |
| GMGIPVLPYPEPAEP | 1141 | Q9UPX0 | |
| VMPRVSIPPYPIAGG | 466 | Q9P246 | |
| MGEPEPPGPDVYQLA | 56 | Q8N1W2 | |
| YPMPQDFVPGPEAGQ | 156 | A0A0J9YWL9 | |
| YEGMGPVLAPVTPVP | 341 | Q06330 | |
| MAGGVDGPIGIPFPD | 1 | O95365 |